Cited 0 times in Scipus Cited Count

Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.

DC Field Value Language
dc.contributor.authorSon, RA-
dc.contributor.authorKim, DY-
dc.contributor.authorPark, SH-
dc.contributor.authorJang, JY-
dc.contributor.authorKim, K-
dc.contributor.authorKim, BJ-
dc.contributor.authorYin, XY-
dc.contributor.authorKim, JH-
dc.contributor.authorMin, BH-
dc.contributor.authorHan, DK-
dc.contributor.authorKim, MS-
dc.date.accessioned2017-05-17T06:30:29Z-
dc.date.available2017-05-17T06:30:29Z-
dc.date.issued2015-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/14018-
dc.description.abstractThe effectiveness of systemic rheumatoid arthritis (RA) treatments is limited by difficulties in achieving therapeutic doses within articular joints. We evaluated the ability of intra-articular administration of injectable formulations to synergistically enhance repair of RA joints. Methotrexate-loaded hyaluronic acid (Met-HA), dexamethasone-loaded microcapsules (Dex-M), and Dex-M dispersed inside Met-HA were prepared as viscous emulsions and injected into articular joints using a needle to form a drug depot. By near-infrared (NIR) fluorescence imaging, we confirmed the local release of NIR from the depot injected into the articular joint over an extended period. In comparison with the subjects treated with Met-HA or Dex-M alone, subjects treated simultaneously with Met-HA and Dex-M exhibited faster and more significant RA repair. Collectively, these results indicated that the drug depot formed after intra-articular injection of Met-HA/Dex-M induced long-lasting drug release and allowed Met and Dex to effectively act in the articular joint, resulting in enhanced RA repair.-
dc.language.isoen-
dc.subject.MESHAnimals-
dc.subject.MESHAnti-Inflammatory Agents-
dc.subject.MESHAntirheumatic Agents-
dc.subject.MESHArthritis, Rheumatoid-
dc.subject.MESHBiomarkers-
dc.subject.MESHCell Line-
dc.subject.MESHChemistry, Pharmaceutical-
dc.subject.MESHDexamethasone-
dc.subject.MESHDisease Models, Animal-
dc.subject.MESHDrug Synergism-
dc.subject.MESHDrug Therapy, Combination-
dc.subject.MESHHumans-
dc.subject.MESHImmunohistochemistry-
dc.subject.MESHInjections, Intra-Articular-
dc.subject.MESHMale-
dc.subject.MESHMethotrexate-
dc.subject.MESHMice-
dc.subject.MESHRats-
dc.subject.MESHSpectroscopy, Near-Infrared-
dc.subject.MESHX-Ray Microtomography-
dc.titleDirect chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.-
dc.typeArticle-
dc.identifier.pmid26424611-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589689/-
dc.contributor.affiliatedAuthor민, 병현-
dc.type.localJournal Papers-
dc.identifier.doi10.1038/srep14713-
dc.citation.titleScientific reports-
dc.citation.volume5-
dc.citation.date2015-
dc.citation.startPage14713-
dc.citation.endPage14713-
dc.identifier.bibliographicCitationScientific reports, 5. : 14713-14713, 2015-
dc.identifier.eissn2045-2322-
dc.relation.journalidJ020452322-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Orthopedic Surgery
Files in This Item:
26424611.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse